| Crude HR (95% CI) | Adjusted HR (95% CI)* | |
|---|---|---|
| ACR/EULAR 2010 vs ACR 1987 | ||
| All subjects (N=676) | 1.83 (1.50, 2.22) | 1.73 (1.34, 2.22) |
| Per protocol (N=413) | 1.79 (1.39, 2.29) | 1.49 (1.11, 2.02) |
| MTX users (N=265) | 1.96 (1.46, 2.64) | 2.18 (1.14, 4.17) |
↵* Adjusted for age, gender, baseline DAS28, symptom duration, MTX dose, glucocorticoid use.